Arrowhead Pharmaceuticals (ARWR) Total Debt Growth (1y) (2012 - 2026)
Arrowhead Pharmaceuticals (ARWR) Total Debt Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 103.99% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 3.84% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Arrowhead Pharmaceuticals | 12.26 Bn | 10.47 Bn | - | -27.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.12% |
| Dec 31, 2025 | -50.39% |
| Sep 30, 2025 | -35.17% |
| Sep 30, 2019 | 28.50% |
| Jun 30, 2019 | 25.08% |
| Mar 31, 2019 | 21.89% |
| Dec 31, 2018 | 1.30% |
| Sep 30, 2018 | -9.63% |
| Jun 30, 2018 | -9.24% |
| Mar 31, 2018 | -8.89% |
| Dec 31, 2017 | -8.55% |
| Sep 30, 2017 | -8.23% |
| Jun 30, 2017 | -7.93% |
| Sep 30, 2013 | -94.04% |
| Jun 30, 2013 | -93.70% |
| Mar 31, 2013 | -93.32% |
| Dec 31, 2012 | -92.88% |
| Sep 30, 2012 | 38.34% |
| Jun 30, 2012 | 41.48% |